MOLECULAR DOCKING STUDY OF NATURALLY OCCURRING COMPOUNDS AS INHIBITORS OF COVID -19

Authors

  • SREEDEVI A Department of Chemistry and Research Centre, Scott Christian College (Autonomous), Nagercoil, Tamil Nadu, India
  • MALAR RETNA A Department of Chemistry and Research Centre, Scott Christian College (Autonomous), Nagercoil, Tamil Nadu, India
  • ROBIN KUMAR SAMUEL Department of Mechanical Engineering, Ponjesly College of Engineering, Nagercoil, Tamil Nadu, India

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i1.43121

Keywords:

COVID-19, Bioactive compound, Cupressuflavone, Binding energy

Abstract

Objectives: The worldwide spread of COVID-19 is an emergent issue to be tackled. Currently, several works in various field have been made in rather short period. The present study aimed to assess bioactive compounds found in medicinal plants as potential COVID-19 Mpro inhibitors using molecular docking study.

Methods: The docking analyses were performed by using Autodock, Discovery Studio Visualiser and Igemdock.

Results: The binding energy obtained from the docking of 6LU7 with native ligand cupressuflavone is -8.9 kcal/mol.

Conclusion: These findings will provide the opportunities to identify the right drug to combat COVID-19.

Downloads

Download data is not yet available.

References

Malik W, Singh Y, Shubhankar S, Sudipta B, Khan S, Kuldeep D, et al. Emerging novel Coronavirus (2019-nCoV)- current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q 2020;40:1-12.

Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS; Thrusting coronaviruses into the spotlight. Viruses 2019;11:59.

Lee PI, Hsush PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect 2020;53:365-7.

Rodriguez-Moralas P, Alfonso J, Kirsten M, Sanch K, Dipti P, et al. Going global-Travel and the 2019 novel coronavirus. Travel Med Infect Dis 2020;33:101578.

World Health Organization. Novel Coronavirus (2019-nCoV). Geneva: World Health Organization; 2020. p. 1-7.

Lu H. Drug Treatment Options for the 2019-new Coronavirus (2019- nCoV). Biosci Trends; 2020.

Xu Z, Peng C, Shi Y, Zhu Z, Mu K, Wang X. Nelfinavir was Predicted to be a Potential Inhibitor of 2019-nCoV Main Protease by an Integrative Approach Combining Homology Modelling. Vol. 1202. Molecular Docking and Binding Free Energy Calculation; 2020.

Zakaryan H, Arabyan E, Oo A, Zandi K. Flavonoids promising natural compounds against viral infections. Arch Virol 2017;162:2539-51.

Thayil M, Sama SP, Thyagarajan. PA-9: A flavonoid extracted formplectranthus amboinicus inhibits HIV-1 protease. Int J Pharmacogn Phytochem Res 2016;8:1020-4.

Jo S, Kim S, Shin DH, Kim MS. Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem 2020;35:145-51.

Ewing TJ, Makino S, Skillmann AG, Kuntz ID. DOCK 4.0: Search strategies of automated molecular docking of flexible databases. J Comp Aided Mol Design 2001;15:411-28.

Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997;267:727-48.

Karmer B, Rarey M, Lengauer T. Evaluation of the FLEXx incremental construction algorithm for protein-ligand docking. Proteins 1999;37:228-41.

Gohlke H, Hendlich M, Klebe G. Knowledge based scoring function to predict protein-ligand interactions. J Mol Biol 2000;295:337-56.

Muegge I, Martin YC. A general and fast scoring function for protein-ligand interaction: A simplified potential approach. J Med Chem 1999;42:91-804.

Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, et al. The protein data bank. Acta Crystallogr D Biol Crystallogr 2002;58:899-907.

Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, et al. Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses 2020;12:244.

Bissantz C, Flokers G, Rognan D. Protein based virtual screening of chemical database-1. Evaluation of different docking/scoring combination. J Med Chem 2000;43:4759-67.

Published

07-01-2022

How to Cite

SREEDEVI A, M. RETNA A, and ROBIN KUMAR SAMUEL. “MOLECULAR DOCKING STUDY OF NATURALLY OCCURRING COMPOUNDS AS INHIBITORS OF COVID -19”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 1, Jan. 2022, pp. 69-71, doi:10.22159/ajpcr.2022.v15i1.43121.

Issue

Section

Original Article(s)